Dr. Mounika Mandadi, MD

Dr. Mandadi practices at Baptist Health La Grange in La Grange, Kentucky, part of Baptist Health.

Dr. Mandadi's NPI, 1164654307, was assigned on August 21, 2009. Dr. Mandadi holds Kentucky license 45366.

Dr. Mandadi's primary practice is Baptist Health La Grange, at 1025 New Moody Lane, La Grange, KY 40031 in Oldham County. The practice phone is (502) 222-5388.

Dr. Mandadi's primary practice is Baptist Health La Grange in La Grange, Kentucky, part of Baptist Health. Dr. Mandadi is also affiliated with Baptist Health Louisville. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Mandadi to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandadi practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mandadi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mandadi is licensed in Kentucky.

CMS data shows 1,539 Medicare services from Dr. Mandadi across 9 procedure codes in 2024, for 441 Medicare patients. Medicare paid $103,820 for them.

CMS counts 441 Medicare patients who saw Dr. Mandadi in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mandadi's median patient age at 66, with 90% women.

In 2024, Dr. Mandadi wrote 1,926 Medicare Part D claims for 434 patients. 86% of them were for generic drugs. CMS names the drug for 1,666 of them, across 31 drugs with 11 or more claims each, at $2,055,671 in total drug cost. In 2023, CMS named 1,349 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Mandadi for performance year 2024, reported through an alternative payment model (APM). Dr. Mandadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mandadi as offering telehealth.

Dmand AI links 3 papers to Dr. Mandadi, published from 2018 to 2019. 2019 was the busiest year, with 2. Dr. Mandadi's most frequent co-authors are Elizabeth C. Riley, MD, Shruti Bhandari, MD and Blakely D. Kute, MD.

Dmand AI links Dr. Mandadi to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Hereditary Sensory and Autonomic Neuropathies and Polyneuropathies.

CMS Open Payments shows 377 general payments to Dr. Mandadi from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Puma Biotechnology, Inc. paid the most, $1,198.